baber/WOPTO huggingface dataset:
Patent AU-4762996-A (AU)
Title: Basket-style carrier with dividing strap
Inventor: HARRELSON GLEN
IPC: B65D71/52
Filed: 1996-01-23
Abstract: A basket-style article carrier for carrying nonbreakable articles. A divider strap is connected to and extends between opposite side panels. The strap is connected to the side panels by a glue flap at each end, one of which is connected by fold line to the upper edge of the associated side panel. The strap causes the carrier to resist bowing when an article is removed, thereby preventing excessive sagging which otherwise tends to allow the remaining articles in the carrier to fall out.
Patent AU-4792996-A (AU)
Title: Human T-cell line infected with HIV-2 which secretes functionally intact HIV-2 GP160
Inventor: SARNGADHARAN MANGALASSERIL GOP
IPC: C12N5/0783
Filed: 1996-03-06
Abstract: A novel cell line chronically infected with HIV-2NIHZ virus secretes the precursor of the viral envelope proteins in extracellular medium. The cells grow well in serum-free medium which enables the concentration of the conditioned medium of the cells to be greatly increased (>100 fold). Such a concentration step is otherwise impossible to achieve if the cells are grown under conventional conditions using 10% fetal calf serum. A specific affinity procedure is provided to purify the gp160 protein from the concentrated conditioned medium of cultures of 100 liter batches using a mouse monoclonal antibody to the HIV-2 gp41 protein, which is a part of the gp160 protein. This purified HIV-2 gp160 reacts with high specificity and sensitivity with the anti viral antibodies of HIV-2 infected humans by several criteria such as i) ELISA, ii) western blot analysis, and iii) radioimmuno-precipitation of metabolically labeled gp160 from the same cell line. The purified HIV-2 gp160 from this cell line is therefore a diagnostic tool for the detection of HIV-2 infection in humans. In view of the predicted oligomeric property of gp160 and its close conformational similarity to the virion envelope, the purified gp160 can also be useful for the development of vaccine strategies against HIV-2 in humans.
Patent AU-4877293-A (AU)
Title: Inhibition of tumor cell growth by administration of B7-transfected cells
Inventor: HELLSTROM INGEGERD
IPC: C12N15/09
Filed: 1993-10-04
Abstract: The present invention is directed to a method of inhibiting tumor cell growth. Tumor cells from a pateint are recombinantly engineered to express the B7 surface protein and these cells are then readminsistered to the pateint. The presence of the B7 molecule on the tumor cell surface stimulates a broad immunologic response against both the B7-transfected and non-transfected tumor cells and results in the immunologic killing of localized and metastatic tumor cells. B7 transfection of the tumor cells, or cell membranes, serves as a stimulant to engender a potent immunologic response against the surface antigens present on the tumor cells. <IMAGE>
Patent AU-4884390-A (AU)
Title: Low calorie fat substitute
IPC: A23L33/20
Filed: 1990-01-24
Abstract: There is disclosed a low calorie fat substitute comprising an outer coating of a digestible fat surrounding an inner core of a low caloric or non-caloric material.
Patent AU-5051298-A (AU)
Title: Method for the production of ivermectin
Inventor: ARLT DIETER
IPC: C07H17/08
Filed: 1997-10-20
Abstract: PCT No. PCT/EP97/05777 Sec. 371 Date Apr. 27, 1999 Sec. 102(e) Date Apr. 27, 1999 PCT Filed Oct. 20, 1997 PCT Pub. No. WO98/18806 PCT Pub. Date May 7, 1998The present invention relates to a process for preparing ivermectin by selective hydrogenation of avermectin and subsequent removal of the catalyst.
Patent AU-5077199-A (AU)
Title: Method to make snow for insect control and device for making the same
Inventor: ELIASSON BERTIL
IPC: C01B32/55
Filed: 1999-07-09
Abstract: The invention relates to a method for bringing about the transformation of a medium such as carbon dioxide or other gases or mixtures thereof into snow. In accordance with the invention, the aforementioned medium and the snow produced from it are caused to interact with surfaces of a snow-producing nozzle extending from a discharge orifice for the medium. The aforementioned medium, after exiting from the discharge orifice, is either permitted to expand into an elongated space which exhibits a uniform cross section. Or the medium is also permitted to act against a number of obstructions in the form of flexible bristles situated along the flow path of the medium as it flows out between the discharge orifice for the medium and an outlet for the formed snow. The produced carbon dioxide snow is intended for use in small animal pest decontamination. Means for producing snow are included in the invention.
Patent AU-5081685-A (AU)
Title: Aminoethyl oxazolidinyl benzene derivatives useful as antibacterial agents
Inventor: GREGORY WALTER ADELMAN
IPC: C07D263/20
Filed: 1985-12-05
Abstract: Novel aminomethyl oxooxazolidinyl benzene derivatives, including ( l )-N[3-[4-(1-hydroxyethyl)-phenyl]-2-oxo-5-oxazolidinylmethyl]acetamide, possess useful antibacterial activity.
Patent AU-5118999-A (AU)
Title: Touch-responsive doll having arm motion
Inventor: MCDONALD DONALD L
IPC: A63H3/48
Filed: 1999-07-21
Abstract: A doll (10) having a soft plush body supports a drive mechanism (60) within the torso (11). A pair of arms (13, 14) are pivotally supported upon the torso (11) and are coupled to the drive mechanism (60) by a pair of slip cam devices. The slip cam devices operate to impart arm motion in accordance with the number and placement of the cams (92, 111) within the slip cam devices. A momentun sensor (96) within the torso (11) activates the drive mechanism (60) in response to touches or impacts upon the doll.
Patent AU-5312586-A (AU)
Title: Composition and method for treatment of tumors with UDPG
Inventor: BALIS M EARL
IPC: A61P35/00
Filed: 1985-12-17
Abstract: UDPG shows tumor-specific inhibition of PRPP and this suggests that this action might prove to be useful in combination therapy with inhibitors of purine and pyrimidine nucleotide systhesis in various rescue regimens. High levels of PRPP in tumors were greatly affected by treatment with UDPG. UDPG can be used in treatment in conjuction with other anti-tumor drugs such as methotrexate, 6-mercaptopurine, 5-fluorouracil or 2,6-dimercaptopurine.
Patent AU-5334690-A (AU)
Title: Intravenous system for delivering a beneficial agent
Inventor: URQUHART JOHN
IPC: A61M39/00
Filed: 1990-03-08
Abstract: A drug formulation chamber for an intravenous administration set is provided. The intravenous administration set includes a container of an IV fluid, a drip chamber, a drug formulation chamber, and an adapter-needle assembly. The drug formulation chamber houses a diffusional or an osmotically driven drug delivery device. The osmotically driven delivery device has a semipermeable, microporous or diffusional wall which surrounds a compartment containing the drug. Drug is delivered through an orifice in the semipermeable/microporous wall or through the diffusional wall itself, into the IV fluid. The device delivers drug into the IV fluid at a rate that is independent of the flow rate of IV fluid through the formulation chamber. The rate of drug delivery is controlled by variably adjusting the surface area of the semipermeable/microporous/diffusional wall that is exposed to the IV fluid flowing through the drug formulation chamber.
Patent AU-5371496-A (AU)
Title: Beta-sheet mimetics and use thereof as inhibitors of biologically active peptides or proteins
Inventor: KAHN MICHAEL
IPC: C07C311/64
Filed: 1996-03-25
Abstract: There are disclosed  beta -sheet mimetics and methods relating to the same for imparting or stabilizing the  beta -sheet structure of a peptide, protein or molecule. In one aspect, the  beta -sheet mimetics are covalently attached at the end or within the length of the peptide or protein. The  beta -sheet mimetics have utility as inhibitors of one or more of proteases, kinases, CAAX, peptides binding to SH2 domains and MHC-I and/or MHC-II presentation of peptides to T cell receptors in warm-blooded animals.
Patent AU-5414598-A (AU)
Title: Method for manufacturing a monolithic plastic object, and an object obtained with this method
Inventor: ROTH CORNELIS WILLEM
IPC: B29C44/10
Filed: 1997-11-20
Abstract: A method for manufacturing a plastic object may include the steps of: (a) providing an injection moulding device with a mould that includes two mould parts which in a closed position define a mould cavity; (b) providing foaming means for causing foaming in the mould cavity of plastic injected into the mould cavity; (c) providing blocking means for temporarily rendering the foaming means effectively inactive; (d) energizing the blocking means; (e) choosing as plastic a mixture of two plastics, wherein the first plastic is a non-type A plastic and the second plastic is a type A plastic that constitutes a maximum of roughly 30 percent by mass of the mixture, wherein the type A plastic is a plastic with high melt strength compatible with the first plastic, for instance HMS PP which is high-melt-strength polypropylene; (f) causing a formed object to cool to a chosen temperature, opening the mould cavity and removing the cooled object.
Patent AU-5526886-A (AU)
Title: Sodium permanganate etch baths containing a co-ion for permanganate and their use in desmearing and/or etching printed circuit boards
Inventor: KRULIK GERALD
IPC: C09K13/02
Filed: 1986-03-26
Abstract: Aqueous, alkaline liquid NaMnO<sub>4</sub> solutions are provided which provide excellent resin desmearing and etchback, especially in the manufacture of printed circuit boards. the solutions comprise water, alkali metal hydroxide, NaMnO<sub>4</sub> and from about 0.1 to about 3.0 moles per mole of Mn04 of a co-ion for MnO<sub>4</sub> selected from the group consisting of K<sup>+</sup>, Cs<sup>+</sup>, Rb<sup>+</sup> and mixtures thereof.
Patent AU-5551601-A (AU)
Title: Methods and compositions for the prevention and treatment of anemia
Inventor: EGRIE JOAN C
IPC: C07K19/00
Filed: 2001-04-19
Abstract: Methods for increasing and maintaining hematocrit in a mammal comprising administering a hyperglycosylated analog of erythropoietin are disclosed. An analog may be administered less frequently than an equivalent molar amount of recombinant human erythropoietin to obtain a comparable target hematocrit and treat anemia. Alternatively, a lower molar amount of a hyperglycosylated analog may be administered to obtain a comparable target hematrocrit and treat anemia. Also disclosed are new hyperglycosylated erythropoietin analogs, methods of production of the analogs, and compositions comprising the analogs.
Patent AU-5582700-A (AU)
Title: Production of agglomerates of inogatran and the compound inogatran anhydrate
Inventor: HORVATH KAROL
IPC: C07K5/02
Filed: 2000-06-06
Abstract: A process for producing spherical agglomerates of inogatran having a narrow size distribution, and the compound inogatran anhydrate.
Patent AU-5840101-A (AU)
Title: Stabilized thermoplastic moulding materials
Inventor: GUNTHERBERG NORBERT
IPC: C08K5/13
Filed: 2001-05-17
Abstract: Thermoplastic molding compositions comprising, based on the components A) to F), A) from 5 to 70% by weight of at least one graft copolymer A) made from an elastomeric graft base with a glass transition temperature below 0° C., and a graft made from a styrene compound, and acryonitrile or methacrylonitrile or a mixture of these and, where appropriate, further monoethylenically unsaturated monomers, B) from 29 to 90% by weight of a hard copolymer made from at least one styrene compound, acrylonitrile or methacrylonitrile or a mixture of these and, where appropriate, further monoethylenically unsaturated monomers, C) from 0 to 5% by weight of at least one three-block copolymer X-Y-X having a central block Y made from propylene oxide units and having terminal blocks X made from ethylene oxide units, D) from 0.01 to 5% by weight of at least one butylated reaction product of p-cresol with dicyclopentadiene, E) from 0.01 to 5% by weight of at least one thiocarboxylic ester, F) from 0.01 to 5% by weight of at least one alkali metal salt or alkaline earth metal salt of a C6-C20 carboxylic acid, and G) from 0 to 30% by weight, based on components A) to G), of other conventional additives,where the weathered db* value of the molding compositions is below +5.0 after 100 hours of exposure to light and weathering to ISO 4892/2, method A, black-panel temperature 65° C., using the CIE-Lab color system, to DIN 6174 and DIN 5033.
Patent AU-5871990-A (AU)
Title: Defoamer for liquid wetting agents and low-foam liquid plant protection agents
Inventor: ALBRECHT KONRAD
IPC: C09K23/20
Filed: 1990-07-06
Abstract: The invention relates to defoamed aqueous surfactant solutions and to low-foam concentrated liquid preparations of plant protection agents which contain sulphate- or sulphonate-containing surfactants as wetting agents and surfactants from the group of the perfluoro-(C6-C18)alkylphosphinic acids and/or -alkylphosphonic acids and/or their salts as defoaming agents.
Patent AU-5901480-A (AU)
Title: Electromagnetic print hammer
Inventor: LEE H C
IPC: B41J9/38
Filed: 1980-06-03
Abstract: An electro-magnetic print hammer comprises a single magnetic hammer element in which an impact mass is coupled to a pivotted armature by flexible stem. The hammer-stem has (N+1/2) periods of oscillation at its resonant frequency during the free flight time of the hammer mass. A permanent magnet with a strong magnetic force which decays rapidly with distance holds the hammer element fixed upon motion of the armature until the armature torque exceeds the magnet holding force to cause the hammer mass to break loose with a snap action. Stop means prevents armature impacts with the operating pole piece of a stator core. The visco-elasticity of the armature stop matches the rebound characteristics of the print medium when impacted by the hammer mass.
Patent AU-6239100-A (AU)
Title: Aqueous suspensions of low solubility and low stability water additives
Inventor: YEOMAN ALAN M
IPC: C09K23/00
Filed: 2000-07-28
Abstract: A method of improving the hydrolytic stability of a hydrolytically unstable compound comprises combining the compound with water and a rheology additive to form an aqueous suspension comprising 1% to 80% of said hydrolytically unstable compound. The rheology additive comprises platelets or particles which orient together with ionic or hydrogen bonds to form a three-dimensional structure.
Patent AU-6315694-A (AU)
Title: Herbicides
Inventor: CAIN PAUL ALFRED
IPC: C07C317/44
Filed: 1994-05-18
Abstract: Herbicides derived from 2-cyano-1,3-diones have the formula: <CHEM> in which R, R<1>, R<2>, R<3>, R<4> and R<5> are as defined in the description. The compounds are intended for use against dicotyledonous and monocotyledonous weeds by pre- and/or post emergence application.
Patent AU-6330700-A (AU)
Title: Microdialysis probe
Inventor: JOHANSSON ROGER
IPC: A61M25/095
Filed: 2000-07-14
Abstract: A microdialysis probe includes a dialysis membrane located and supported between a closed distal end of the probe and a proximal end of the same, which membrane essentially-surrounding a space for passage of perfusion liquid. The probe has an inlet and outlet for perfusion liquid. The probe exhibits a deformable mesh sleeve adapted to enclose and protect at least the dialysis membrane, the proximal end of the deformable being fastened to the probe between the proximal end of the probe and the dialysis membrane.
Patent AU-6373500-A (AU)
Title: De-icing composition and method
Inventor: BYTNAR STEPHEN C
IPC: C09K3/18
Filed: 2000-07-25
Abstract: A composition for reducing the buildup of snow and ice on a surface. The composition includes a sugar-water mixture combined with a steepwater solubles-water admixture.
Patent AU-6484694-A (AU)
Title: Controlled release formulations coated with aqueous dispersions of ethyl cellulose
Inventor: OSHLACK BENJAMIN
IPC: A61K9/52
Filed: 1994-06-20
Abstract: The invention concerns controlled release oxycodone dosage forms comprising a multiparticulate system substrate comprising an amount of an oxycodone salt, the substrate being coated with an aqueous dispersion of at least one hydrophobic polymer, whereby the coating provides controlled release, the substrate including an additional dose of an oxycodone salt included in either the controlled release coating or in an additional overcoating coated on the outer surface of the controlled release coating, whereby the dosage forms, comprising the cured, coated substrate, comprise an effective amount of an oxycodone salt and provide a therapeutic effect for at least 12 hours when administered to a patient.
Patent AU-6504300-A (AU)
Title: In vivo high throughput toxicology screening method
Inventor: FOGARTY PATRICK
IPC: C12Q1/04
Filed: 2000-07-31
Abstract: A high throughput toxicology screening method is provided. In the subject method, at least 10 different compound compositions are tested simultaneously. Each compound composition is tested by contacting it with a plurality, e.g. from about 10 to 1000, of non-mammalian multi-cellular organisms and determining the effect of the compound composition on the organisms. The multi-cellular organisms employed in the subject methods are small, have differentiated tissues and organs and have a rapid generation time. The subject high throughput screening methods find use in a variety of applications, and are particularly suited for use in the toxicology screening of libraries of compounds, such as libraries of combinatorially produced compounds.
Patent AU-6553200-A (AU)
Title: Mechanically regulated timepiece
Inventor: MOCK ELMAR
IPC: G04B33/08
Filed: 2000-08-31
Abstract: The invention concerns a timepiece with mainspring of the so-called fly tourbillon type, the tourbillon having a balance bridge ( 2 ) forming a cage with a collet ( 1 ) and a single protruding ball bearing ( 5 ) supporting said so-called fly tourbillon assembly. Said so-called fly tourbillon assembly is visible on the dial side ( 15 ) and is designed as an independent tourbillon module. Said tourbillon module is separable from the clockwork ( 13 ) by being detached on the rear side of the clockwork ( 13 ) and by being removed on that same side.
Patent AU-6614698-A (AU)
Title: Flat strip lamellas for reinforcing building components and method for their production
Inventor: BLEIBLER ALEXANDER
IPC: E04G23/02
Filed: 1998-01-20
Abstract: Flat strip lamella for reinforcing weight-carrying or weight-transferring building components. It has a composite structure consisting of a plurality of pliant or loose-flex supporting fibers (26) aligned parallel to each other, and a binding matrix (28) which connects the supporting fibers to each other so that they are shear-resistant, and is fastenable by means of an adhesive (16) by its broad side to the surface of the building component (12) that is to be reinforced. So that the flat strip lamella, to which the binding matrix gives rigid elastic form, can also be bent over corner edges of a building component (12), the invention proposes that the binding matrix (28) be removed, in at least an intermediary area (30), by uncovering the supporting fibers (26), and that the uncovered supporting fibers be subjected to a liquid or pasty thermosetting plastic, in order to stabilize the bent-over condition.
Patent AU-6735794-A (AU)
Title: A method of treating cardiovascular disorders using a combination of a renin angiotensin system inhibitor and an endothelin antagonist
Inventor: CLOZEL JEAN-PAUL
IPC: A61P9/10
Filed: 1994-07-08
Abstract: Pharmaceutical combination products which contain an inhibitor of the renin-angiotensin system ("RAS inhibitor") and an endothelin antagonist are described. These products are suitable for controlling or preventing hypertension and its sequelae and for treating heart failure.
Patent AU-6801994-A (AU)
Title: Manufacture of n-phosphonomethylglycine and its salts
Inventor: HODGKINSON IAN
IPC: B01J23/644
Filed: 1994-05-27
Abstract: N-Phosphonomethylglycine and its salts are manufactured by hydrolysing N-phosphonomethyl-2-oxazolidinone in an aqueous medium and thereafter oxidising the hydrolysis product in an aqueous alkaline medium using an oxygen-containing gas in the presence of an oxidation catalyst, for example a platinum or palladium catalyst optionally containing a promoter such as bismuth.
Patent AU-6839994-A (AU)
Title: Dna encoding prostaglandin receptor ep1
Inventor: FORD-HUTCHINSON ANTHONY
IPC: C12N5/10
Filed: 1994-05-25
Abstract: A novel prostaglandin receptor has been identified and DNA encoding the receptor has been isolated, purified, sequenced and expressed in host cells. This DNA encoding the novel prostaglandin receptor and host cells expressing the receptor are used to identify modulators of the prostaglandin receptor.
Patent AU-6869398-A (AU)
Title: Use of chelerythrine and radiation for tumor therapy
Inventor: WEICHSELBAUM RALPH R
IPC: A61K31/4741
Filed: 1998-03-25
Abstract: Combination of low doses of irradiation and chelerythrine results in increased apoptosis in tumor cells. The doses of either irradiation or chelerythrine alone are such that increased apoptosis or decreased tumor growth or proliferation would not be expected.
Patent AU-6890894-A (AU)
Title: Aminobenzoic acid derivatives
Inventor: MIYAZAWA SHUHEI
IPC: C07D451/04
Filed: 1994-08-05
Abstract: An aminobenzoic acid derivative represented by the following general formulas (I), (I-2) or (I-3), or a pharmacologically acceptable salt thereof, which exhibits a serotonin antagonism and an acetylcholine release accelerating activity at a well-balanced activity ratio and which is efficacious as a drug for patients with gastrointestinal unindentified complaints: <CHEM>  and <CHEM> wherein R<1> represents a group such as an alkynyl or cyanoalkyl group; R<2> represents a group such as an amino or acylamino group; R<3> represents a halogen atom; X represents -O- or -NH-; and A represents an oxygen or sulfur atom.
Patent AU-6979787-A (AU)
Title: Two-stage melt reduction of iron ore with gas afterburning
Inventor: TURNER RICHARD EDWIN
IPC: C21B13/14
Filed: 1987-03-06
Abstract: A method for two-stage melt reduction of iron ore, in which iron ore is prereduced substantially to wustite and at the same time melted down in a melting cyclone, and then liquid hot metal is produced in an iron bath reactor connected to the outlet of the melting cyclone and receiving the melted wustite by adding carbonaceous fuels and oxidizing gas to the melt. The resulting reaction gas from the melt is afterburned, and the dust-laden, partly burned reaction gases from the iron bath reactor are accelerated and further afterburned by adding a hot blast with a temperature of 800 DEG  C. to 1500 DEG  C., and at least a portion of such accelerated, after burned reaction gases are introduced into the melting cyclone to reduce and melt fresh iron ore.
Patent AU-7460998-A (AU)
Title: Hook-shaped arrangement
Inventor: OHLSON KURT LENNART
IPC: G09F3/14
Filed: 1998-05-04
Abstract: The present invention relates to a hook-shaped arrangement (1) which comprises a main part (1a), a hook-shaped device (1b) integral with said main part, and a holding means (2) which is integral with or attached to said main part. The hook-shaped device (1b) is comprised of a tongue (5) which is part-circular, or at least essentially part-circular in cross section and has an angle of arc slightly below 360°. The center (5') of the curved tongue is located in a plane (A) which coincides with a plane (A') that lies on one side surface (7) of the main part. The free end (5a) of the tongue extends in a plane (B) that coincides with a plane (B') lying on that side surface (8) of the main part opposite to said one side surface (7) of said main part.